Testes 8 Special Order
- Manufacturer
- Uriel Pharmacy Inc.
- Effective date
- 2018-05-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:57:29
Label at a glance#
ProductTestes 8 Special Order
Active ingredientBOS TAURUS TESTICLE
Label structure9 sections
Contacts and useful links#
Websitewww.urielpharmacy.com
www.urielpharmacy.com
www.urielpharmacy.comLabel contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Directions: FOR ORAL USE.
DOSAGE & ADMINISTRATION SECTION
Take the contents of one ampule under the tongue and hold for 30 seconds, then swallow.
OTC - ACTIVE INGREDIENT SECTION
Active Ingredient: Testes (Bovine testes) 8X
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Water, Salt
OTC - PURPOSE SECTION
Use: Promotes healthy balance of homologous organs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN.
WARNINGS SECTION
Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Do not use if allergic to any ingredient. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use.
OTC - QUESTIONS SECTION
Questions? Call 866.642.2858
Uriel, East Troy, WI 53120
www.urielpharmacy.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- Testes 8 Special Order
- BOS TAURUS TESTICLE
- WATER
- SODIUM CHLORIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 48951-9341 | 48951-9341-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BOS TAURUS TESTICLE | PR4RXL6G2H | ACTIB |
| WATER | 059QF0KO0R | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b5f9649f-2c78-30c2-e053-2a95a90a4c30 | 6ce30cff-ad85-38af-e053-2a91aa0acd79 | 2020-12-08 | Warnings | 6ce30cff-ad85-38af-e053-2a91aa0acd79 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.